New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...
Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, ...